Sumitomo Pharma Co., Ltd.
Sumitomo Pharma Co., Ltd. (DNPUF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · DNPUF · as of Jun 9, 2026
Key Statistics
Explore Sumitomo Pharma Co., Ltd. Data
dnpuf stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 1 · Buy rate: 0.0%
Competitors & Peers
dnpuf competitorsDNPUF
CZMWF
CZMWY
HKMPY
HLUBF
LVZPFStock Performance
Full HistoryAbout Sumitomo Pharma Co., Ltd.
Sumitomo Pharma Co., Ltd. is a global enterprise specializing in the manufacturing and distribution of a diverse portfolio of products, including pharmaceuticals, food ingredients and additives, chemi…
what is sumitomo pharma co., ltd. · dnpuf stock overview · sumitomo pharma co., ltd. company profile · who is sumitomo pharma co., ltd. ceo · dnpuf OTC · sumitomo pharma co., ltd. headquarters · sumitomo pharma co., ltd. business segments
About Stock Overview & Key Data
Sumitomo Pharma Co., Ltd. (DNPUF) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on OTC since Jan 17, 2012. As of the latest trading session, DNPUF stock price is $10.50, with a market capitalization of $4.7B. The stock has returned +60.80% over the past 12 months and -26.88% year-to-date.
According to 1 Wall Street analysts, the consensus rating for Sumitomo Pharma Co., Ltd. stock is Hold, with an average 12-month price target of $—. In fiscal year 2026, Sumitomo Pharma Co., Ltd. reported revenue of $456.1B and net income of $107.5B. For detailed data — including Sumitomo Pharma Co., Ltd. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Sumitomo Pharma Co., Ltd. (DNPUF) stock price is $10.50. The stock is traded on OTC under the ticker symbol DNPUF. The 52-week range is $6.34 – $19.20.